title: Molecular mediators of alphavbeta3-induced endothelial cell survival.
abstract: The alphavbeta3 integrin interaction with the extracellular matrix (ECM) plays an essential role in inhibiting apoptosis in endothelial cells. We have recently shown that alphavbeta3 ligation on rat aortic endothelial cells (RAECs) specifically activates the transcription factor nuclear factor kappaB (NF-kappaB) and promotes cell survival. Inhibiting NF-kappaB nuclear translocation abolished the protective effect of alphavbeta3 ligands. Here, we report that ligation of alphavbeta3 by its ligand, osteopontin (OPN), induces the phosphorylation and activation of inhibitory kappa B kinase beta IKKbeta and promotes the specific degradation of inhibitory kappa Balpha (IkappaBalpha) in RAECs. Overexpression of a dominant negative (DN) IKKbeta protein prevents IkappaBalpha phosphorylation, NF-kappaB activation, and inhibits the protective effects of OPN. The NF-kappaB-inducing kinase (NIK) has been shown to be one of the upstream kinases involved in IKK activation. OPN-mediated NF-kappaB activity is increased upon NIK wild-type (WT) overexpression and blocked following NIK DN overexpression. In addition, NIK-/-mouse embryonic fibroblasts (MEFs) plated on OPN display reduced NF-kappaB activity and decreased IkappaBalpha phosphorylation compared to NIK+/+MEFs. Finally, functional inhibition of integrin beta3-dependent NF-kappaB signaling decreases OPN-induced IkappaBalpha, IKKbeta and NIK phosphorylation. These studies for the first time show that the alphavbeta3-NF-kappaB-dependent endothelial survival pathway is dependent on IkappaBalpha, IKKbeta, and NIK.
authors.affiliation: Department of Pathology, University of Washington, Seattle 98195-1720, USA.
authors.forename: Julie
authors.initials: J
authors.lastname: Rice
authors.forename: Donald L
authors.initials: DL
authors.lastname: Courter
authors.forename: Cecilia M
authors.initials: CM
authors.lastname: Giachelli
authors.forename: Marta
authors.initials: M
authors.lastname: Scatena
mesh_terms: D000818:Animals; D001011:Aorta; D002470:Cell Survival / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D004789:Enzyme Activation; D051550:I-kappa B Kinase / Q000378:metabolism; D039302:Integrin alphaVbeta3 / Q000502:physiology*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D016328:NF-kappa B / Q000502:physiology; D053495:Osteopontin; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D051381:Rats; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012795:Sialoglycoproteins / Q000235:genetics / Q000494:pharmacology / Q000502:physiology; D014162:Transfection; D000097782:NF-kappaB-Inducing Kinase
chemical_list: D051550:I-kappa B Kinase; D039302:Integrin alphaVbeta3; D020928:Mitogen-Activated Protein Kinases; D016328:NF-kappa B; D053495:Osteopontin; D017346:Protein Serine-Threonine Kinases; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; D000097782:NF-kappaB-Inducing Kinase; C506896:Spp1 protein, mouse; C506897:Spp1 protein, rat